A rodent vendor health status report (also called a health monitoring report or colony health report) is a periodic document a commercial breeder — Charles River, Jackson Laboratory, Taconic Biosciences, Envigo/Inotiv, and similar suppliers — publishes for each production colony or barrier room, listing which pathogens the colony has been tested for and the result of each test. Receiving institutions use these reports at the procurement and animal-receipt stage to decide whether incoming rodents can go straight into an existing colony, need quarantine, or require rederivation before they can enter a barrier facility. This guide covers what the reports actually contain, how to read them, and how they fit into an institution’s procurement and animal-care workflow.
What the report actually documents
A vendor health status report is not a certificate that an animal is “disease-free” in some absolute sense. It is a record of a defined, recurring surveillance program: a set of sentinel or in-colony animals is sampled on a schedule, and each sample is tested against a fixed panel of agents the vendor has agreed to exclude from that specific colony. The report states, room by room and date by date, which agents were tested for and whether each came back positive or negative (“excluded” or “not detected”). Typical panels drawn from the rodent-relevant agents FELASA (the Federation of European Laboratory Animal Science Associations) has published health-monitoring recommendations around include:
- Viruses — e.g., mouse hepatitis virus (MHV), Sendai virus, minute virus of mice (MVM), mouse parvovirus (MPV), Theiler’s murine encephalomyelitis virus (TMEV), pneumonia virus of mice, and epizootic diarrhea of infant mice virus, depending on species and program.
- Bacteria — e.g., Mycoplasma pulmonis, Helicobacter spp., Pasteurella pneumotropica, CAR bacillus (Filobacterium rodentium), and, for some programs, Citrobacter rodentium and beta-hemolytic Streptococcus.
- Parasites — pinworms (Syphacia/Aspiculuris) and fur mites (Myobia, Myocoptes, Radfordia), which spread readily through direct contact and bedding and are among the most common reasons a shipment triggers quarantine.
Reports typically specify the testing method used for each agent (serology, PCR, culture, or direct observation), the sample size and sentinel program design, and the date range the results cover — all of which matter for interpreting a result, not just the positive/negative call itself.
Why the report matters at the procurement stage
Most institutional biosafety and animal-care programs, and AAALAC International-accredited facilities in particular, require documented evidence of a source colony’s health status before animals from that source can be approved to enter an existing barrier colony. A current vendor health status report is the standard way that evidence is provided; a purchase order or shipping manifest with no accompanying health report is generally not sufficient for an IACUC-approved receiving protocol. Building the report into procurement means:
- Requesting the most recent report for the specific colony/room the animals will ship from — not a generic vendor-wide document — before or alongside the order.
- Confirming the report’s date is within the receiving institution’s own currency window (commonly 3-6 months, though this varies by program and is set locally, not by a universal rule) rather than accepting an outdated report on file.
- Routing the report to the institution’s veterinary staff or IACUC-designated reviewer as part of animal receipt, alongside the shipment itself.
- Filing the report with the receiving record so it is available for the next AAALAC or internal program review.
What happens when the panel doesn’t match, or a result is positive
Two situations commonly require a decision beyond “accept the shipment”:
- Panel mismatch. If the vendor’s excluded-agent list doesn’t match the receiving colony’s own exclusion list (a newer barrier room may exclude agents an older vendor report doesn’t test for, or vice versa), the receiving institution typically requires either supplemental testing or a period of quarantine with local sentinel testing before the animals join the main colony.
- Positive result. A positive finding for an excluded agent doesn’t necessarily end the transaction, but it does trigger a decision: hold the shipment, request retesting, redirect the animals to a quarantine or restricted room instead of the barrier colony, or — where the line is a genetically unique or otherwise irreplaceable one — pursue rederivation.
Rederivation: the fallback when a line can’t simply be re-sourced
Rederivation is the process of producing pathogen-free offspring from an infected or status-unknown line, most commonly via embryo transfer (harvesting embryos and implanting them into a pathogen-free surrogate dam) or, less commonly today, hysterectomy/cesarean-section derivation followed by cross-fostering. It is used when a specific genetic line carries value that can’t simply be replaced by ordering from a cleaner vendor colony — a proprietary transgenic or knockout line, for example — and the receiving institution needs it to enter a barrier facility that the current health status doesn’t support. Rederivation is slower and more resource-intensive than simply re-ordering, so most procurement decisions resolve at the report-review or quarantine stage rather than reaching this point.
Institutional sentinel programs vs. vendor reports
A vendor health status report documents the source colony at the vendor’s facility. It does not substitute for the receiving institution’s own ongoing sentinel health-monitoring program, which tracks the health status of animals already inside the institution’s own rooms after they arrive, are housed, and are potentially exposed to other sources (other vendors, investigator-transferred lines, equipment, personnel traffic). Both are necessary and serve different points in the animal’s lifecycle at the institution: the vendor report is a receiving-stage screening tool, and the institutional sentinel program is ongoing surveillance once the animals are on site.
Frequently asked questions
How often do vendors publish updated health status reports?
This varies by vendor and by colony, but major commercial breeders typically update reports on a recurring basis (commonly quarterly for many production rooms), and always in response to a positive finding. Always request the most current report available for the specific source room rather than relying on a cached copy from a previous order.
Do all vendors test for the same pathogen panel?
No. Panels vary by vendor, by colony type (e.g., barrier-maintained specific-pathogen-free colonies vs. conventional colonies), and by species. This is exactly why comparing the vendor’s excluded-agent list against the receiving institution’s own exclusion list, rather than assuming “health report on file” is a single uniform standard, is the actual review step.
Who at an institution should review the report before animals are approved to enter a colony?
Typically institutional veterinary staff or an IACUC-designated animal health reviewer, as part of the animal-receipt process defined in the institution’s animal care and use program — not left solely to the ordering investigator or lab manager.
Is a health status report the same as an AAALAC accreditation document?
No. AAALAC International accreditation evaluates an institution’s overall animal care and use program; a vendor health status report is a colony-specific pathogen-surveillance document that AAALAC-accredited programs commonly require as supporting evidence during animal receipt, but the two are not interchangeable.
